Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574645 | 1.00 | PMP22 (0.48) | PMP22ALOX15BLMKMT2AGSR | |
| SCHEMBL1527399 | 1.00 | PMP22 (0.48) | PMP22ALOX15BLMKMT2AGSR | |
| Alanine SCHEMBL6762705 | 0.93 | NOS3 (0.44) | PMP22ALOX15BLMKMT2AGSR | |
| Alanine SCHEMBL6762703 | 0.93 | NOS3 (0.44) | PMP22ALOX15BLMKMT2AGSR | |
| Adipic Acid SCHEMBL8058451 | 0.89 | BHMT (0.50) | PMP22ALOX15BLMKMT2AGSR | |
| Arginine SCHEMBL6374054 | 0.88 | OTC (0.56) | PMP22ALOX15BLMKMT2AGSR | |
| Arginine SCHEMBL288132 | 0.88 | OTC (0.56) | PMP22ALOX15BLMKMT2AGSR | |
| Arginine SCHEMBL2411547 | 0.88 | OTC (0.56) | PMP22ALOX15BLMKMT2AGSR | |
| Arginine SCHEMBL7928810 | 0.88 | OTC (0.56) | PMP22ALOX15BLMKMT2AGSR | |
| Arginine SCHEMBL1790 | 0.88 | OTC (0.56) | PMP22ALOX15BLMKMT2AGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 931 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091126-A1 | AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY | UNIV MISSOURI (US) | 2026-04-02 | — | — | US | claimed |
| EP-4702986-A1 | POLYPEPTIDE AND USE THEREOF | Biocells (Beijing) Biotech Co., Ltd. (CN) | 2026-03-04 | — | — | EP | claimed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | claimed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | claimed |
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | UNIV ERASMUS MED CT ROTTERDAM (NL) | 2025-11-13 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| EP-4590670-A1 | PLATFORM AND SCAFFOLD FOR FAP TARGETING AGENTS | Erasmus University Rotterdam Medical Center (NL) | 2025-07-30 | — | — | EP | claimed |
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | SAREPTA THERAPEUTICS, INC. (US) | 2025-05-29 | — | — | US | claimed |
| EP-3833676-B1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-120022230-A | Peroxide hydrogel and preparation method thereof | 千氧生物技术(上海)有限公司 | 2025-05-23 | — | — | CN | claimed |
| EP-0585412-B1 | INCREASING BLOOD-BRAIN BARRIER PERMEABILITY WITH PERMEABILIZER PEPTIDES | ALKERMES INC (US) | 1999-07-07 | — | — | EP | claimed |
| EP-0561412-B1 | Parathyroid hormone derivatives | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-02-03 | — | — | EP | claimed |
| EP-0885900-A2 | Increasing blood-brain barrier permeability with permeabilizer peptide derivatives of bradykinin | ALKERMES, INC. (US) | 1998-12-23 | — | — | EP | claimed |
| WO-1998053051-A1 | SHORT PEPTIDES WHICH SELECTIVELY MODULATE INTRACELLULAR SIGNALLING | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-11-26 | — | — | WO | claimed |
| WO-1998053050-A2 | SHORT PEPTIDES WHICH SELECTIVELY MODULATE THE ACTIVITY OF SERINE/THREONINE KINASES | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-11-26 | — | — | WO | claimed |
| US-5686416-A | BRADYKININ ANALOGUES; NONA-, DECA- AND POLYPEPTIDES | ALKERMES, INC. (US) | 1997-11-11 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-5506206-A | ARGININE-PROLINE-HYDROXYPROLINE-GLYCINE-THIENYLALANINE-SERINE -(4-METHYL-TYROSINE)-ARGANINE OR A CONFORMATIONAL ANALOGUE, USED AS THERAPEUTICAL OR DIAGNOSTIC AGENTS | ALKERMES, INC. (US) | 1996-04-09 | — | — | US | claimed |
| EP-0585412-A1 | INCREASING BLOOD-BRAIN BARRIER PERMEABILITY WITH PERMEABILIZER PEPTIDES | ALKERMES, INC. (US) | 1994-03-09 | — | — | EP | claimed |
| WO-1992018529-A1 | INCREASING BLOOD-BRAIN BARRIER PERMEABILITY WITH PERMEABILIZER PEPTIDES | ALKERMES, INC. (US) | 1992-10-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | SSTR2, SSTR5, SSTR1 | PMP22 4296/4885ALOX15 4502/4885BLM 3001/4885 |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | ACE2, SARS1, TMPRSS2 | PMP22 3755/4885ALOX15 4068/4885BLM 3124/4885 |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | PMP22 3746/4885ALOX15 2769/4885BLM 541/4885 |
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | MYOF, TNNC1, MTPN | PMP22 460/4885ALOX15 2687/4885BLM 2089/4885 |
| US-20260091126-A1 | AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY | METTL16, SLC7A1, RNMT | PMP22 3790/4885ALOX15 792/4885BLM 3778/4885 |
| US-12540161-B2 | Linkers | ADM2, CDA, DCTD | PMP22 3167/4885ALOX15 3617/4885BLM 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.